A detailed history of Russell Investments Group, Ltd. transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 3,730 shares of STTK stock, worth $4,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,730
Holding current value
$4,103
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.0 - $4.85 $11,190 - $18,090
3,730 New
3,730 $13,000
Q3 2022

Nov 04, 2022

BUY
$2.6 - $5.52 $163,423 - $346,959
62,855 Added 189.57%
96,012 $259,000
Q2 2022

Jul 29, 2022

BUY
$2.7 - $4.59 $89,523 - $152,190
33,157 New
33,157 $134,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.